# CONMED (CNMD) — News

CNMD · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/cnmd/news

## Recent headlines

- [ConMed sees FY adj EPS $4.48 to $4.60, saw $4.30 to $4.45](https://www.ainvest.com/news/conmed-sees-fy-eps-4-48-4-60-4-30-4-45-2607) — AInvest Wire, Jul 29, 2026
  CONMED Corporation (NYSE: CNMD) has raised its full-year 2025 EPS guidance to a range of $4.48 to $4.60, up from its previous forecast of $4.25 to $4.40. The updated outlook reflects continued operational improvements and progress in addressing supply chain challenges that impacted parts of the…
- [Needham says Conmed worth $46-$53 per share in a takeover](https://www.ainvest.com/news/needham-conmed-worth-46-53-share-takeover-2607) — AInvest Wire, Jul 13, 2026
  Needham & Company has revised its price target for CONMED Corporation (NYSE: CNMD), suggesting the medical device company could be valued between $46 and $53 per share in the event of a potential takeover. This assessment follows reports that CONMED is exploring strategic options after receiving…
- [Conmed is said to weigh sale after takeover interest - Bloomberg News](https://www.ainvest.com/news/conmed-weigh-sale-takeover-interest-bloomberg-news-2607) — AInvest Wire, Jul 10, 2026
  Conmed Corporation (NYSE: CNMD) is reportedly considering a potential sale following emerging takeover interest, according to recent market reports . The company’s stock has shown notable volatility in response to the speculation, with shares rising on news of the reported interest. While no formal…
- [Conmed is said to weigh sale after takeover interest](https://www.ainvest.com/news/conmed-weigh-sale-takeover-interest-2607) — AInvest Wire, Jul 10, 2026
- [Conmed Corp: BMO initiates coverage with market perform rating; target price $36](https://www.ainvest.com/news/conmed-corp-bmo-initiates-coverage-market-perform-rating-target-price-36-2607) — AInvest Wire, Jul 9, 2026
  BMO Capital Markets has initiated coverage of Conmed Corp (NYSE:CNMD), assigning the stock a "market perform" rating and establishing a target price of $36 . The decision follows a comprehensive review of the company’s financial performance, market positioning, and growth prospects. Analysts…

## Similar Stocks

- [MMSI](https://www.lighthorse.io/tickers/mmsi) — Merit Medical Systems, Inc. - Common Stock

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).